Vijaya Diagnostic Centre Ltd (VIJAYA) is currently trading at 1,427.55 per share. Stock prices fluctuate during market hours on NSE and BSE based on demand, company updates, and overall market conditions. Refer to the live price chart above for the most recent price movement.

Vijaya Diagnostic Centre operates an integrated, predominantly B2C diagnostic network offering pathology, radiology, wellness testing, imaging, home collections and digital report access. With 168 centres across 27 cities and towns, 18 NABL-accredited laboratories and more than 400 doctors, the company combines centralized capabilities with a dense hub-and-spoke distribution model. Q2 FY27 delivered a notable combination of scale and operating leverage: revenue rose 26.7% year-on-year while EBITDA increased 37.8%, lifting margin to 44.1%. Test volumes grew 16.5%, but revenue per test increased to ₹513, indicating improved realization and service mix alongside volume-led expansion. Geographic concentration remains high but is gradually declining. Hyderabad contributed 67% of Q2 revenue versus 72% in FY25, while RoAPT contributed 20%; newer markets such as Pune, West Bengal and Bengaluru are increasing their combined contribution as centres mature and brand awareness develops. The company is moving beyond conventional diagnostics through clinically applied AI, including automated kidney-stone analysis for CT KUB and AI-powered dental radiograph interpretation. These tools are positioned to improve reporting speed, diagnostic precision, surgical planning and patient communication, although the presentation does not quantify their direct revenue contribution. Management is pursuing simultaneous organic densification and inorganic entry into new territories. Planned hubs and spokes across Hyderabad, AP, Karnataka, West Bengal and RoAPT are complemented by the proposed Arya Wellness acquisition, which provides an immediate platform for North-East expansion and broadens the company’s national footprint.

Over the past 52 weeks, Vijaya Diagnostic Centre Ltd has traded between a low of ₹847.90 and a high of ₹1,592.00. The 52-week high and low indicate the stock’s price range over the last year and help investors understand its volatility and recent trading levels.

Vijaya Diagnostic Centre Ltd has a market capitalization of approximately 14,759.06. Market capitalization represents the total value of a company’s outstanding shares and helps investors understand its size, stability, and relative risk compared to other listed companies.

Vijaya Diagnostic Centre Ltd’s investment profile depends on its business fundamentals, valuation, and long-term outlook. The stock currently trades at a PE ratio of 72.46 and operates in the its sector sector. Investors typically assess financial performance, growth prospects, and individual risk tolerance before making investment decisions.

Based on its market capitalization of 14,759.06 Cr, Vijaya Diagnostic Centre Ltd is classified as a Small Cap stock. Large-cap stocks are generally more stable, while mid-cap and small-cap stocks tend to offer higher growth potential along with higher price volatility.

Vijaya Diagnostic Centre Ltd operates in the its sector sector. Sector classification matters because companies in the same sector are often affected by similar economic conditions, regulatory changes, and competitive dynamics, which can influence overall stock performance.

The Price-to-Earnings (PE) ratio of Vijaya Diagnostic Centre Ltd is 72.46. The PE ratio compares a company’s share price to its earnings and is commonly used to assess valuation. Comparing the PE ratio with sector peers and historical levels provides better context.

Vijaya has disclosed transaction consideration of Rs 46.2 crore for Arya Wellness Centre. The presentation does not provide a payment schedule or divide the amount into upfront and contingent components.

Vijaya Diagnostic Centre reported an EBITDA margin of 44.1% in Q2 FY27. This was 355 basis points above 40.6% in Q2 FY26 and 149 basis points above 42.7% in Q1 FY27.

Vijaya plans 10 centres in H2 FY27, comprising three hubs and seven spokes. The plan follows nine centres launched in H1 FY27, comprising two hubs and seven spokes.

Vijaya generated Rs 270.6 crore of net cash from operating activities in FY26, compared with Rs 224.5 crore in FY25. Cash generated from operations before direct taxes was Rs 322.8 crore, and direct taxes paid were Rs 52.2 crore.